• Cytokinetics granted inducement equity awards on June 15, 2026 to 12 new employees who started in May–June.
• Awards cover stock options for 24,784 shares, 16,429 restricted stock units, 2,242 performance stock units.
• Options carry a $ USD 71.38 exercise price, vest over four years, hold a 10-year term.
• RSUs vest over three years: 40% year one, 40% year two, 20% year three.
• PSUs depend on two performance goals; earned shares vest 50% at certification, 50% one year later.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytokinetics Incorporated published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606171600PRIMZONEFULLFEED9748776) on June 17, 2026, and is solely responsible for the information contained therein.